MedPath

江西亿友药业有限公司

Ownership
-
Established
2015-12-09
Employees
-
Market Cap
-
Website
http://www.cnyiyou.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

15

NMPA:15

Drug Approvals

Azithromycin Granules

Product Name
阿奇霉素颗粒
Approval Number
国药准字H20254025
Approval Date
Apr 30, 2025
NMPA

Piracetam Injection

Product Name
吡拉西坦注射液
Approval Number
国药准字H20243101
Approval Date
Jan 30, 2024
NMPA

Bromhexine Hydrochloride Oral Solution

Product Name
盐酸溴己新口服溶液
Approval Number
国药准字H20243131
Approval Date
Jan 30, 2024
NMPA

Piracetam Injection

Product Name
吡拉西坦注射液
Approval Number
国药准字H20243100
Approval Date
Jan 30, 2024
NMPA

Bromhexine Hydrochloride Oral Solution

Product Name
盐酸溴己新口服溶液
Approval Number
国药准字H20223978
Approval Date
Sep 14, 2023
NMPA

复方公英胶囊

Approval Number
国药准字Z20080335
Approval Date
Apr 27, 2023
NMPA

千里光胶囊

Approval Number
国药准字Z20090216
Approval Date
Apr 27, 2023
NMPA

Bromhexine Hydrochloride Granules

Product Name
盐酸溴己新颗粒
Approval Number
国药准字H20223655
Approval Date
Sep 14, 2022
NMPA

Bromhexine Hydrochloride Injection

Product Name
盐酸溴己新注射液
Approval Number
国药准字H20213658
Approval Date
Aug 25, 2021
NMPA

Piracetam Tablets

Product Name
吡拉西坦片
Approval Number
国药准字H36021012
Approval Date
Nov 12, 2020
NMPA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.